Impact of adjuvant radiotherapy on survival outcomes in super-elderly patients with triple negative breast cancer: a population-based cohort study
Super elderly patients (aged ≥ 85 years) with triple-negative breast cancer (TNBC) are markedly underrepresented in clinical trials. The survival benefit of adjuvant radiotherapy (RT) in this population remains unclear. This study aimed to evaluate the impact of adjuvant RT on overall survival (OS) in super-elder...